CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Gastroenterology Année : 2022

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

1 University of Calgary
2 University of Ljubljana
3 UMCL - University Medical Centre Ljubljana [Ljubljana, Slovenia]
4 UC San Diego - University of California [San Diego]
5 Amsterdam UMC - Amsterdam University Medical Centers
6 All India Institute of Medical Sciences [New Delhi]
7 University Hospital Erlangen = Uniklinikum Erlangen
8 FAU - Friedrich-Alexander Universität Erlangen-Nürnberg = University of Erlangen-Nuremberg
9 University of Manitoba [Winnipeg]
10 Imelda General Hospital
11 SPH-UBC - St. Paul’s Hospital - University of British Columbia [Vancouver, BC, Canada]
12 University of Adelaide
13 Cleveland Clinic
14 MSSM - Icahn School of Medicine at Mount Sinai [New York]
15 UniSR - Universita Vita Salute San Raffaele = Vita-Salute San Raffaele University [Milan, Italie]
16 IRCCS Ospedale San Raffaele [Milan, Italy]
17 Goethe-Universität Frankfurt am Main
18 Cedars-Sinai Medical Center
19 University of Otago [Dunedin, Nouvelle-Zélande]
20 Northwestern University [Chicago, Ill. USA]
21 NPH - Northwick Park Hospital [Harrow, UK]
22 PUCPR - Pontifícia Universidade Católica do Paraná [Curitiba, Brasil] = Pontifical Catholic University of Paraná [Curitiba, Brazil] = Université catholique pontificale du Paraná [Curitiba, Brésil]
23 UHH - Universität Hamburg
24 McGill University = Université McGill [Montréal, Canada]
25 Semmelweis University [Budapest]
26 The University of Sydney
27 Universidade do Porto = University of Porto
28 IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer
29 NGERE - Nutrition-Génétique et Exposition aux Risques Environnementaux
30 Service d'Hépato-gastro-entérologie [CHRU Nancy]
31 Shanghai Jiao Tong University [Shanghai]
32 Hunimed - Humanitas University [Milan]
33 IRCCS S. Maria Nascente - Istituto di Ricovero e Cura a Carattere Scientifico
34 MSH - Mount Sinai Hospital [Toronto, Canada]
35 University of Toronto
36 John Radcliffe Hospital [Oxford University Hospital]
37 Erasmus MC - Erasmus University Medical Center [Rotterdam]
38 UC - University of Cincinnati
39 EMily (UMR_S_1160 / U1160) - Ecotaxie, microenvironnement et développement lymphocytaire
40 AP-HP - Hopital Saint-Louis [AP-HP]
41 CHU-Liège - Centre Hospitalier Universitaire de Liège
42 The University of Chicago Medicine [Chicago]
43 Weill Cornell Medicine [Cornell University]
44 DHMC - Dartmouth Hitchcock Medical Center
45 University Hospitals Leuven [Leuven]
46 KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven
47 UWO - University of Western Ontario
Christopher Ma
Benjamin Cohen
  • Fonction : Auteur
Miguel Regueiro
  • Fonction : Auteur
Takayuki Yamamoto
  • Fonction : Auteur
Amy Lightner
  • Fonction : Auteur
Claire Parker
  • Fonction : Auteur
Stefanie Mcfarlane
  • Fonction : Auteur
Leonardo Guizzetti
  • Fonction : Auteur
Michelle Smith
  • Fonction : Auteur
Geert D’haens
  • Fonction : Auteur
A. Hillary Steinhart
  • Fonction : Auteur
C. Janneke van der Woude
  • Fonction : Auteur

Résumé

End points to determine the efficacy and safety of medical therapies for Crohn's disease (CD) and ulcerative colitis (UC) are evolving. Given the heterogeneity in current outcome measures, harmonizing end points in a core outcome set for randomized controlled trials is a priority for drug development in inflammatory bowel disease.

Dates et versions

hal-04165953 , version 1 (19-07-2023)

Identifiants

Citer

Christopher Ma, Jurij Hanzel, Remo Panaccione, William Sandborn, Geert d'Haens, et al.. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. Gastroenterology, 2022, 163 (4), pp.950-964. ⟨10.1053/j.gastro.2022.06.068⟩. ⟨hal-04165953⟩
10 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More